ArticleMolecules (Basel, Switzerland)2026
Ultrafast Self-Assembly of Efficient Blue-Excitable Hybrid Manganese Bromide Microcrystals for Wide-Gamut Display Backlights.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Blue-excitable lead-free metal halide microcrystals (MCs) with high efficiency and narrow emission are highly desired for next-generation wide-gamut displays. Herein, an ultrafast self-assembly strategy is developed to prepare hybrid manganese bromide MCs with tunable alkyl-chain lengths. With increasing alkyl-chain length, the emission intensity of the obtained MCs first improves significantly and then deteriorates, accompanied by a gradual narrowing of the full width at half maximum (FWHM) from 46.37 to 41.97 nm. The optimized [(C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.